20 results
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
under federal health care programs. Promotional materials for approved drugs must be submitted to the FDA in conjunction with their first use … from federal health care programs. In addition, the government may assert that a claim including items or services resulting from a violation
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:45pm
under federal health care programs. Promotional materials for approved drugs must be submitted to the FDA in conjunction with their first use … from federal health care programs. In addition, the government may assert that a claim including items or services resulting from a violation
10-K
2023 FY
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Annual report
4:48pm
under federal health care programs. Promotional materials for approved drugs must be submitted to the FDA in conjunction with their first use or first … federal health care programs. In addition, the government may assert that a claim including items or services resulting from a violation
424B4
CHRO
Chromocell Therapeutics Corp.
20 Feb 24
Prospectus supplement with pricing info
5:30pm
for distribution to patients and a communication plan to health care practitioners. Furthermore, if we or others later identify undesirable side effects caused … . and internationally. The escalating cost of health care has led to increased pressure on the health care industry to reduce costs. Drug pricing
424B4
CHRO
Chromocell Therapeutics Corp.
20 Feb 24
Prospectus supplement with pricing info
5:28pm
, a medication guide outlining the risks of the product for distribution to patients and a communication plan to health care practitioners. Furthermore, if we … may be increasingly restricted both in the U.S. and internationally. The escalating cost of health care has led to increased pressure on the health care industry
DRS/A
owjdchonq399chf
17 Oct 22
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next